Behavioral Neurology & Neuropsychiatry — Specialty Profile

Exploratory, not prescriptive. This profile blends hard data (pay, match rates, burnout, demographics, each sourced and dated) with generalizations and synthesized opinion about culture and "who fits." It's here to help you get curious and go find out for yourself, not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Last reviewed: 2026-08-04.

Also called: BNNP, behavioral neurology, cognitive neurology, neuropsychiatry, dementia or memory-disorders neurology. A 1–2 year UCNS-accredited fellowship entered after a neurology, child neurology, or psychiatry residency, not a residency you match into from medical school. Organ system: the brain, specifically the part of it that produces memory, language, personality, and judgment.

Subspecialty fellowship of Neurology, and of Psychiatry.

The 30-second version

Behavioral neurology is the field that treats the brain as the organ of the mind, and it is one of the few subspecialties you can enter from either a neurology residency or a psychiatry one and arrive at the same certificate, and the only one whose whole subject matter sits on the seam between them. The clinical territory is everything that goes wrong with cognition and behavior when the tissue is damaged: Alzheimer's disease and the other dementias, frontotemporal degeneration where a person's character changes years before their memory does, primary progressive aphasia, traumatic brain injury, autoimmune encephalitis, and the neuropsychiatric symptoms that ride along with Parkinson's, Huntington's, and multiple sclerosis. Much of the diagnostic work is done by talking, since the examination here is a structured cognitive assessment rather than a reflex hammer, and the fellowship is as much about learning to interpret neuropsychological testing and structural imaging as about learning to prescribe. The field has just been through the biggest change in its history: anti-amyloid antibodies mean that for the first time there is a disease-modifying drug to offer, along with an infusion schedule, a biomarker workup, and an MRI surveillance protocol that did not exist five years ago. The trade at the center of the field: enormous and growing demand, genuine intellectual depth, and a subspecialty that pays less than the general neurology you would be doing otherwise.

Quick dashboard (details and sources below)


Training after med school	5–6 years (4 yr neurology or 4 yr psychiatry + 1–2 yr BNNP fellowship)
Total from college start	~13–14 years (4 undergrad + 4 med school + 4 residency + 1–2 fellowship)
Training chain	Med school (4) → Neurology (4) or Psychiatry (4) → 1–2 yr UCNS BNNP fellowship → UCNS certification exam
Competitiveness (as a UCNS fellowship)	Low to moderate. Non-ACGME, no ABPN board, 44 accredited programs, and no published match; demand for graduates far exceeds supply ⟳
Typical full-time pay	Society survey · AAN 2025 (2024 data). No BNNP line exists. Practice is academic-heavy, where the neurologist median is $277,288 (n=2,464), against $309,882 for general neurology (n=474) ⟳
Pay vs. general neurology	A discount rather than a premium, and the discount is mostly the academic setting ⟳
Lifestyle	Outpatient, daytime, clinic-based, essentially no acute or overnight call. Long visits are the defining feature ⟳
Burnout	No BNNP figure; inherit neurology (~44%, sources vary) minus the call burden, plus a sustained grief load ⟳
% women	No subspecialty figure; inherit neurology at 33% practicing (2022) and 50.2% of residents (AY2024-25) ⟳
DO / IMG accessibility	Parent neurology runs 18.8% DO and 22.4% IMG of its filled PGY-1 positions, against 21.5% and 25.2% across all PGY-1 positions; the open step is the fellowship, which is non-ACGME and undersubscribed ⟳

What they actually do

Behavioral neurologists diagnose and manage disorders of cognition, behavior, and personality that arise from brain disease. The largest share of the work is neurodegenerative: Alzheimer's disease, dementia with Lewy bodies, frontotemporal dementia, primary progressive aphasia, progressive supranuclear palsy, and vascular cognitive impairment. Around that core sits a wide neuropsychiatric practice covering traumatic brain injury, autoimmune and paraneoplastic encephalitis, functional neurological disorder, and the apathy, psychosis, disinhibition, and depression that accompany Parkinson's disease, Huntington's disease, and multiple sclerosis.¹²

The defining diagnostic instrument is the history, and it is a two-person history. A patient with a memory disorder is frequently the least reliable narrator of it, so the visit depends on an informant, usually a spouse or an adult child, and a large part of the skill of the field is running a conversation in which the patient is respected while the family says something the patient cannot. On top of that sits a structured cognitive examination that goes far beyond a bedside screen, plus interpretation of neuropsychological test batteries, structural MRI, and, increasingly, molecular biomarkers.

Representative work: detailed cognitive and behavioral examination, including language, praxis, visuospatial, memory, and executive testing · interpretation of formal neuropsychological batteries, usually in partnership with a neuropsychologist · structural MRI reading for atrophy patterns, since where the brain thins tells you which disease it is · amyloid PET, tau PET, CSF biomarkers, and the newer blood-based markers · lumbar puncture · diagnostic disclosure conversations · capacity and driving-safety assessments · management of behavioral symptoms in dementia, which is mostly non-pharmacological and mostly carried out through the caregiver · anti-amyloid antibody therapy, including eligibility assessment, infusion oversight, and surveillance imaging.¹³

A day in the life: clinic, and clinic that runs long. New-patient evaluations in a memory center are commonly scheduled at 60 to 90 minutes, because the history, the informant interview, the cognitive examination, and the family discussion do not compress. A typical day is a small number of new evaluations and a larger number of follow-ups, punctuated by reviewing outside imaging and neuropsychological reports. Academic practitioners split the week with research, teaching, and multidisciplinary conference, where cases are discussed alongside neuropsychology, neuroradiology, psychiatry, social work, and sometimes neuropathology.

What is largely absent is acute work. There is no procedural suite, no overnight call rota driven by this field's own diseases, and no emergency version of a memory clinic. Inpatient consultation exists at academic centers, mostly for encephalitis, rapidly progressive dementia, and delirium that will not resolve, but it is a minority of the practice.

The part that changed recently. Anti-amyloid monoclonal antibodies moved Alzheimer's care from diagnosis and support to diagnosis, eligibility, treatment, and monitoring. Lecanemab requires confirmation of elevated beta-amyloid by amyloid PET or lumbar puncture before treatment, an MRI before starting, and ApoE ε4 genotyping to stratify the risk of amyloid-related imaging abnormalities. It is given by IV infusion every two weeks, with a once-every-four-weeks maintenance option approved in January 2025 and a weekly subcutaneous maintenance option in August 2025. It slows decline rather than reversing it, and it cannot restore what has already been lost.³ Whatever you conclude about the size of that benefit, the workflow it creates is now a real part of the job, and it landed on a workforce that was already too small.

The training path & time to completion

Medical school (4 yrs) → either a neurology residency (PGY-1 intern year + 3 years) or a psychiatry residency (4 years) → 1–2 year UCNS-accredited Behavioral Neurology & Neuropsychiatry fellowship → UCNS subspecialty certification exam.¹⁴

Two front doors, one certificate. UCNS eligibility requires ABMS certification, or the Canadian or osteopathic equivalent, in neurology, child neurology, and/or psychiatry.⁴ A handful of other subspecialties do accept both feeders — brain injury medicine, sleep medicine, pain medicine and hospice and palliative medicine among them — but each sits anatomically in one place; here the two feeder residencies disagree with each other about what the object of study even is, and the fellowship exists precisely at that seam.
Fellowship length is one or two years, and programs offer both. A representative UCNS-accredited program runs either 12 or 24 months with 12 months of clinical training in both configurations, the second year being research.¹ If you want an academic career, and most people in this field do, the two-year version is the realistic one.
Accreditation is UCNS rather than ACGME. The United Council for Neurologic Subspecialties accredits BNNP the same way it accredits neurocritical care, headache medicine, and neuro-oncology. Sponsoring institutions must themselves be ACGME- or CanERA-accredited, and accreditation is a voluntary peer-review process rather than a regulatory requirement.⁵ The sibling neuro-oncology and headache medicine profiles describe the same arrangement.
The certificate is a UCNS diplomate credential, not an ABPN board. The examination is offered biennially. As of the most recent count, 439 physicians in the United States and Canada hold UCNS certification in behavioral neurology and neuropsychiatry, which tells you the true size of the formally credentialed field.⁴ ⟳
Total from the start of college: about 13 to 14 years, which is a year or two beyond general neurology's 12.

Fellowship supply, in context. There are 44 UCNS-accredited BNNP programs, out of 251 UCNS-accredited training programs across all of its subspecialties.⁴⁵ Most take one or two fellows. Against a disease burden of 7.4 million Americans aged 65 and older living with Alzheimer's in 2026, projected toward roughly 13 million by 2050, that is a very small pipeline.⁶ ⟳

How competitive is it?

There is no published match rate, because there is no centralized match. BNNP fellowships recruit independently, on their own timelines, without an NRMP or SF Match cycle to generate statistics. Anyone quoting a competitiveness figure for this field is estimating.

What can be said with sources:

The open step is the fellowship, and the residency is an ordinary door. Neurology ran 18.8% DO and 22.4% IMG of its filled PGY-1 positions in 2026, against 21.5% and 25.2% across all PGY-1 positions, so the parent sits just under the usual rate on both axes; psychiatry has broadened substantially. The parent neurology profile covers this. The UCNS year beyond either residency is where the room is, being non-ACGME with capacity nobody is filling.⁷
The fellowship is not the bottleneck. The interest is. 44 accredited programs against a national dementia burden measured in millions means positions are not the scarce resource. Cognitive fellowships across neurology have historically had trouble filling, and the closest structural sibling, movement disorders, runs roughly a quarter of its positions unfilled. Behavioral neurology publishes no equivalent figure, but it shares the features that produce that outcome: non-ACGME, no ABPN board, and a pay discount against general neurology. ⟳
Demand for graduates is the opposite of competitive. In the Alzheimer's Association's survey work, 55% of primary care physicians report that there are not enough dementia specialists in their community, and half report feeling unprepared to manage Alzheimer's themselves.⁶ The average Medicare patient referred to any neurologist waits 34 days, and 18% wait more than 90.⁸

The honest read. This is a field you enter because you want it, not one you win. The selection pressure sits at strong academic programs with famous memory centers, where research fit and mentorship decide the outcome, and it is close to absent elsewhere. If you want to do this work, you can almost certainly train to do it. The scarcity in this field is on the employer's side of the table, which is an unusual and genuinely favorable position for a trainee.

Board status: UCNS certification in Behavioral Neurology & Neuropsychiatry, examined biennially. There is no ABPN subspecialty board in this field, and the credential is voluntary. Many academic memory-center positions expect it; general neurology practice does not require it.⁴

Compensation — the robust version

Start with what the field's own survey does and does not report. The American Academy of Neurology runs the largest compensation survey dedicated to neurology, and its 2025 edition drew 4,352 respondents, 3,457 of them neurologists, reporting on 2024 performance. The public executive summary breaks out four subspecialties, and behavioral neurology is not one of them.⁹ So there is no published BNNP median, and every specific "behavioral neurology salary" you find online is an aggregator estimate.

What the AAN survey does show is the two comparisons that matter most here.

By subspecialty, neurologist median annual compensation runs:

Subspecialty	n	Median
Vascular neurology & stroke	312	$315,913
General neurology	474	$309,882
Epilepsy	362	$282,386
Child neurology	300	$256,082

By practice setting, the spread is wider than the spread across subspecialties:

Setting	n	Median
Hospital-based group	278	$362,500
Multispecialty group	105	$350,000
Neurology group	259	$315,489
Solo practice	31	$300,000
Academic medical center–based group	2,464	$277,288

⁹ ⟳

Read those two tables together and the compensation story for this field falls out. Behavioral neurology practice is concentrated in academic medical centers and hospital-affiliated memory centers, because that is where the neuropsychology, the imaging, the infusion capacity, and the research infrastructure live. The academic median of $277,288 is roughly $33,000 below general neurology and roughly $85,000 below a hospital-based group. The subspecialty training is not what costs you the money. The setting the subspecialty exists in is.

Why the economics work this way. This is a cognitive field in the literal billing sense: the revenue comes from evaluation and management codes rather than procedures, and the visits are long. A 90-minute new dementia evaluation with an informant interview and cognitive testing does not generate the work-RVUs that a 90-minute procedural block does, and the academic neurologist wRVU median of 2,969 against 4,863 for hospital-based groups shows the same fact from the productivity side.⁹ Cognitive care in the United States is undervalued relative to procedural care, and behavioral neurology sits at the far cognitive end of a specialty that already sits at that end.

Where the upside is, honestly. Anti-amyloid therapy brings infusion, imaging, and biomarker workflows into the memory clinic, which is the first substantial procedural and technical revenue this field has had. Whether that translates into higher salaries for behavioral neurologists rather than into institutional revenue is an open question, and it is too early for survey data to answer it. Outside academia, dementia care is also a genuine private and hospital-employed market in an aging country, and a behavioral neurologist in a hospital-based group is drawing from a very different median.

One more comparison, because the AAN's numbers will look low against everything else you read. The two national physician surveys put neurology well above the AAN's neurologist medians: $341,000 in Medscape's 2026 report on 2025 earnings and $360,519 in Doximity's 2025 report on 2024 earnings.⁹ ⟳ That gap is a difference of instrument rather than a contradiction. Both national surveys publish means across a mixed employment base, while the AAN publishes medians from a member panel that is 2,464 academics deep, and a mean pulled upward by high private earners is a different statistic from a median dominated by academic salaries. For a field that lives in academic memory centers, the AAN figure is the more relevant one. Quote whichever you like, name it, and do not average them.

Limited-data caveat: the AAN's full dashboard covers up to 22 subspecialties and is available to members for $500 and nonmembers for $2,000; the free executive summary carries only the four subspecialty lines above. If you are seriously considering this field, the full dataset is the place to look for a BNNP line.⁹ ⟳

Lifestyle

This is one of the most controllable lives in neurology, and the controllability is structural rather than negotiated.

Outpatient, daytime, scheduled. Memory-clinic practice is clinic practice. There is no procedural suite to staff and no acute presentation of the field's own diseases that requires you overnight.
Call is light and often absent. Where it exists it is general neurology call taken as a departmental obligation rather than anything generated by cognitive disorders. Compared with the acute stroke call that shapes general neurology, this is a large quality-of-life difference.
The hours are set by visit length rather than volume. Long appointments mean fewer patients per day, which sounds restful and is not quite: the documentation load per patient is heavy, the reports from neuropsychology and radiology have to be read carefully, and family phone calls between visits are constant.
The caregiver contact is unbounded in a way schedules do not capture. A patient with progressive dementia has a family in crisis around them, and the messages, calls, and letters for disability, driving, guardianship, and long-term care do not fit inside the appointment. This is real, uncompensated work, and it is the part practitioners in this field name most often when asked what wears on them.
Geographic flexibility is moderate. Academic memory centers cluster at universities. Dementia patients are everywhere, so a hospital-employed or community cognitive practice is possible in many places, but the research-heavy jobs are not.

Lifestyle rating: 4/5. Daytime, outpatient, minimal call, and genuinely part-time-viable, with deductions for documentation burden and for the between-visit caregiver load that no schedule shows.

Wellbeing — the part to take seriously

No BNNP-specific burnout figure has been published. Inherit neurology, which the parent profile places in the elevated range, with sources conflicting between roughly 44% and the high 40s to low 50s.⁷ Then adjust in two directions, because this field differs from general neurology on both.

The call burden that drives a lot of neurology burnout is largely absent here, and that is a real protective factor. Acute stroke call, night coverage, and the emergency-department consult stream are not part of this practice.

The emotional load is different in kind, and it is sustained rather than acute. You diagnose diseases that are progressive and, for the most part, not curable. You then follow the same patient and the same family for years while the person recedes. The grief in this field is anticipatory rather than sharp, a slow loss you are present for repeatedly, across a whole panel of patients at different stages, and there is no procedural win to break it up. Practitioners describe the compensating satisfaction as coming from the diagnosis itself, since a family that finally has a name for what is happening is genuinely helped, and from the caregiver relationship, which becomes a therapeutic relationship in its own right.

The frustration named most often is systemic rather than clinical. Access is the problem: 55% of primary care physicians report too few dementia specialists in their community, half feel unprepared to manage these patients, and the referral queue arrives at a very small number of trained clinicians.⁶ Working in a field where the constraint on doing good is the size of your own workforce is a specific kind of moral fatigue.

The new therapies cut both ways on wellbeing. Having a disease-modifying option to offer is a substantial change from a field whose entire clinical repertoire was recently diagnosis and support. It also brings eligibility disappointments, since most patients referred are past the mild-cognitive-impairment or mild-dementia window in which lecanemab is indicated, and telling a family that the drug they read about is not for them is now a recurring conversation.³

Who's in the field (demographics)

Subspecialty-specific demographic data is essentially absent for this field, which is what happens when the certified population is 439 people. Inherit the parent specialties and treat everything here as directional.

Women: no BNNP figure. Parent neurology runs 33% women among practicing physicians (2022) and 50.2% of residents in AY2024-25; psychiatry is higher on both.⁷ Because this field draws from both, its gender composition is plausibly closer to the midpoint than to neurology alone, but that is an inference rather than a measurement. ⟳
DO: no BNNP figure. Neurology gave 18.8% of its filled PGY-1 positions to DO graduates in 2026, a little under the 21.5% across all PGY-1 positions, and a non-ACGME fellowship with unfilled capacity adds no filter of its own.⁷ ⟳
IMG: no BNNP figure. Neurology runs 22.4% IMG of its filled PGY-1 positions, against 25.2% across all PGY-1 positions, and well below internal medicine, pathology, and family medicine. Undersubscribed fellowships are typically more open than the residencies that feed them, which is the argument for expecting international graduates here in real numbers.⁷ ⟳
Underrepresented in medicine: no data specific to this field. The patient population is disproportionately affected in ways the workforce is not: Black and Hispanic older adults carry higher dementia prevalence and are diagnosed later, which makes workforce composition a clinical issue here rather than only an equity one.⁶ ⟳

Culture, personality & the online stereotypes

Who gravitates here: people who found the history the most interesting part of medicine. Behavioral neurology attracts clinicians who like sitting with a complicated story and reasoning from it, who are comfortable that the exam is a conversation, and who are unbothered by long visits. There is a strong academic and research orientation, a heavy overlap with neuropsychology and cognitive science, and an unusual number of people who came in through psychiatry and stayed for the anatomy or came in through neurology and stayed for the people. It also self-selects for tolerance of slow, unresolvable disease. As always, plenty of people in the field do not fit any single mold.

The stereotypes. Community perception rather than fact, each with a kernel and an unfair edge:

"The field where you diagnose and then have nothing to offer." The oldest criticism of cognitive neurology, and the one that has aged worst. It was always overstated, since diagnosis, caregiver support, symptom management, and safety planning are substantial help, and it is now factually outdated for the subset of patients eligible for anti-amyloid therapy.³
"Neurology's philosophy department." The perception that this is the most academic, least practical corner of an already cerebral specialty. The kernel is real, since the field is genuinely research-heavy and genuinely interested in questions about mind and brain. The unfair edge is that memory-clinic practice is intensely practical work about driving, finances, safety, and family strain.
"Neither neurologists nor psychiatrists fully claim it." A structural observation more than a jab. A fellowship enterable from two residencies, accredited by neither's primary board, sits slightly outside both. Practitioners tend to treat this as the point of the field rather than a defect in it.
"You take a pay cut to do more work per patient." Accurate, on the AAN numbers, and the field does not really dispute it.⁹

What people say online (synthesized and paraphrased, not quotes): across trainee and physician forums, the recurring behavioral neurology threads are about whether the fellowship is worth doing at all, given that a general neurologist can see cognitive patients without it and be paid more. The most common answer is that the fellowship buys you the academic memory-center job and the ability to run a complex differential in atypical and young-onset cases, and buys you nothing if you plan to practice general neurology. The second recurring thread is the neurology-versus-psychiatry entry question, where the consensus is that the residency you choose should be the one whose four years you actually want, since both lead to the same fellowship. The third, and the newest, is anti-amyloid therapy, where the tone is markedly split between clinicians who consider it the beginning of real treatment and those who consider the effect size too small for the infusion burden and ARIA risk. The overall register is thoughtful and low-drama, notably free of the competitiveness anxiety that dominates other specialty threads.

Voices from the field. Paraphrased from published sources, with links to the originals:

The AAN's 2025 compensation survey, the largest dedicated to neurology, documents the two facts that shape this career financially: subspecialty medians clustered near or below general neurology, and a roughly $85,000 gap between academic and hospital-based practice settings.⁹
A Neurology study published in January 2025, drawn from two years of Medicare claims covering 163,313 beneficiaries, 84,975 referring physicians, and 10,250 neurologists, found an average 34-day wait for a neurology appointment, with 18% waiting more than 90 days.⁸
The Alzheimer's Association's annual report puts 7.4 million Americans aged 65 and older living with Alzheimer's in 2026, heading toward roughly 13 million by 2050, with 55% of primary care physicians reporting too few dementia specialists in their communities.⁶
UCNS accredits 44 behavioral neurology and neuropsychiatry fellowship programs and has certified 439 diplomates across the United States and Canada, with the examination offered biennially.⁴⁵

Why people choose it / why people leave

Why choose it: the intellectual heart of clinical neurology, where anatomy and personality are the same subject · a diagnostic craft built on history and examination rather than on a machine · demand that vastly exceeds supply, which means job security and leverage · a controllable outpatient life with minimal call · relationships with patients and families that run for years · a field that has just acquired disease-modifying therapy for the first time, so the next decade of it will not look like the last · the two-door entry, which lets a psychiatrist do neurology and a neurologist do psychiatry without abandoning either.

Why leave or avoid it: a real pay discount against general neurology, driven mostly by the academic setting the field lives in · a non-ACGME fellowship and a voluntary certificate rather than an ABPN board · sustained anticipatory grief across an entire patient panel, with no procedural relief · heavy uncompensated work in documentation, forms, and caregiver contact · therapies that help some patients modestly and leave most referrals ineligible · concentration of the best jobs at academic centers, which constrains geography.

Best fit if: the history and the cognitive exam are the parts of medicine you would happily spend a career on · you want to work with families as much as with patients · you are comfortable with diseases you cannot cure · you want an academic career and are willing to trade income for it · you came out of residency still unsure whether you were more interested in neurology or psychiatry.

Not for you if: you want procedures or acute care · you need the pay a procedural or hospital-based path offers · slow decline you cannot stop would wear you down · you want a formal ABMS board at the end · you need geographic freedom more than you need an academic center.

The FLI angle — Behavioral neurology & neuropsychiatry for first-gen, low-income & immigrant students

Where it fits FLI realities well:

The second gate is the low one, and that is rare for a field this intellectually prestigious. Neurology runs 18.8% DO and 22.4% IMG of its filled PGY-1 positions, against 21.5% and 25.2% across all PGY-1 positions, so the residency is an ordinary door.⁷ The fellowship past it is non-ACGME with capacity that exceeds demand. Compare that with the two-gate structure of dermatology or the pedigree sensitivity of the surgical subspecialties, where the second gate is the harder one.
PSLF fits this path unusually well. The practice is concentrated at academic medical centers and nonprofit hospitals, which are exactly the employers that qualify, and residency and fellowship years count toward the 120 payments. For a path where the income is modest by physician standards, forgiveness is a materially better lever than paying down aggressively.
The job market favors you rather than the employer. With 55% of primary care physicians reporting too few dementia specialists in their communities and a certified national workforce of 439, a graduate of this fellowship has real choice about where to work.⁶⁴
The work itself may be closer to home than you expect. Immigrant and first-generation families frequently do dementia caregiving inside the household rather than through paid services, and clinicians who understand that dynamic from the inside, and who speak the family's language, are scarce and badly needed.

Risks to name honestly:

The income is the real cost, and you should model it rather than wave at it. The academic neurologist median of $277,288 is a good living and a low figure by physician standards, roughly $33,000 below general neurology and $85,000 below hospital-based neurology.⁹ Against a median medical student debt burden, that difference compounds over a career. This is the single most important number for an FLI student weighing this field.
The general-neurology alternative is genuinely open. You can see cognitive patients as a general neurologist, be paid more, and skip the fellowship years. The fellowship buys the academic job and the atypical-case expertise. If neither is what you want, it is one to two years of trainee income spent on a credential you will not use.
Academic careers reward capital you may not have. Research output, mentorship, and time on unfunded projects are how the strong memory-center jobs are won, and protected research time is easier to accept when nobody is depending on your salary. Read this alongside the Money section on supporting family during training.
Geography constrains the best version of the job. The research-heavy positions are at universities. A community or hospital-employed cognitive practice is available in more places and pays better, so if staying near family matters, aim at that version deliberately rather than by default.

Bottom line for FLI: this is an intellectually serious field whose second gate is unusually low, with an employment market that needs you more than you need it and a PSLF fit that suits a modest income. The cost is the income itself, and it is a real cost rather than a rounding error. Choose it because the work is what you want to do for thirty years, and go in having done the arithmetic on the difference against general neurology rather than discovering it in your first contract.

Fun facts

UCNS eligibility explicitly accepts board certification in neurology, child neurology, and/or psychiatry, so a neurologist and a psychiatrist reach the identical certificate through different residencies.⁴
The whole certified field would not fill a lecture hall. 439 physicians in the United States and Canada hold UCNS certification in behavioral neurology and neuropsychiatry, against 7.4 million Americans aged 65 and older living with Alzheimer's.⁴⁶
Where the brain thins tells you which disease it is. Medial temporal atrophy points toward Alzheimer's, frontal and anterior temporal toward behavioral-variant FTD, left perisylvian toward primary progressive aphasia. Pattern recognition on structural MRI is a core skill of the field.
The exam is only offered every other year. UCNS certification in this subspecialty is examined biennially, so missing a cycle costs you two years.⁴
Subspecializing here costs money rather than earning it. On the AAN's own numbers, every neurology subspecialty broken out in the public summary except stroke has a lower median than general neurology.⁹
A patient with dementia waits in the same queue as everyone else. Medicare patients referred to neurology wait 34 days on average, and 18% wait more than three months.⁸

Sources

Fellowship structure and clinical scope. University Hospitals Cleveland Medical Center, Behavioral Neurology and Neuropsychiatry Fellowship — a UCNS-accredited "one- to two-year" fellowship, either 12 or 24 months in duration with 12 months of clinical training in both configurations, based in the Brain Health and Memory Center, with research opportunity in cognition and behavior. https://www.uhhospitals.org/medical-education/neurology-medical-education/fellowships/behavioral-neurology-and-neuropsychiatry-fellowship (accessed 2026). ↩ ↩² ↩³ ↩⁴
Clinical territory of behavioral neurology and neuropsychiatry (neurodegenerative disease, TBI, autoimmune encephalitis, functional neurological disorder, neuropsychiatric symptoms of neurologic disease), and the field's position between neurology and psychiatry. Society for Behavioral and Cognitive Neurology, Accreditation and Certification. https://the-sbcn.net/accreditation-and-certification (accessed 2026). ↩
Anti-amyloid therapy workflow. Alzheimer's Association — Lecanemab (Leqembi): traditional FDA approval for early Alzheimer's; eligibility limited to mild cognitive impairment or mild dementia due to Alzheimer's with confirmed elevated beta-amyloid; amyloid PET or lumbar puncture confirmation and baseline MRI required before treatment; ApoE ε4 genotyping encouraged for ARIA risk; IV infusion every two weeks, with once-every-four-weeks IV maintenance approved January 2025 and weekly subcutaneous maintenance approved August 2025; slows decline without restoring lost function. https://www.alz.org/alzheimers-dementia/treatments/lecanemab-leqembi ⟳ ↩ ↩² ↩³ ↩⁴
UCNS accreditation and certification in Behavioral Neurology & Neuropsychiatry — 44 UCNS-accredited BNNP training programs; 439 physicians in the US and Canada hold UCNS certification in the subspecialty; eligibility requires ABMS certification (or RCPSC/AOA equivalent) in neurology, child neurology, and/or psychiatry plus current US or Canadian licensure; certification examination offered biennially (2024 cycle: early application deadline May 1, 2024; testing the week of November 18–22, 2024). Society for Behavioral and Cognitive Neurology, Accreditation and Certification. https://the-sbcn.net/accreditation-and-certification (accessed 2026). ⟳ ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰
UCNS accreditation as a system — 251 UCNS-accredited training programs across its recognized subspecialties (Behavioral Neurology & Neuropsychiatry, Clinical Neuromuscular Pathology, Headache Medicine, Neonatal Neurocritical Care, Neurocritical Care, Neuro-oncology); accreditation is a voluntary process of evaluation and peer review; sponsoring institutions must be ACGME- or CanERA-accredited; nine programs accredited effective June 1, 2025, one of them in BNNP (Emory). American Academy of Neurology, "Nine programs receive UCNS accreditation," July 9, 2025. https://www.aan.com/news/nine-programs-ucns-accreditation-application-deadline ⟳ ↩ ↩² ↩³
Disease burden and specialist access. Alzheimer's Association, Alzheimer's Disease Facts and Figures — an estimated 7.4 million Americans aged 65 and older living with Alzheimer's in 2026, projected to roughly 13 million by 2050 and 13.8 million by 2060; health and long-term care costs projected at $409 billion in 2026; nearly 13 million Americans providing unpaid dementia care (about 19 billion hours, valued at $446 billion); 55% of primary care physicians report inadequate dementia specialists in their communities and 50% report feeling unprepared to treat Alzheimer's patients. https://www.alz.org/alzheimers-dementia/facts-figures ⟳ ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷
Parent-field figures. Neurology typical comp ~$340k–$362k, from the neurology profile on this site. Burnout: Medscape Physician Burnout & Depression Report 2024 (n=9,226, fielded July–October 2023) puts neurology at 44% against a 49% all-physician average; the higher ~48–55% figures come from other instruments and years, which is why the two conflict. The primary report is paywalled and returns HTTP 402, so the row comes from two independent relays that agree with each other: Healthgrades Pro (https://resources.healthgrades.com/pro/the-most-and-least-burned-out-physicians-by-specialty) and Advisory Board (https://www.advisory.com/daily-briefing/2024/01/31/physician-burnout). Women practicing, 33%: AAMC, "Women are changing the face of medicine in America" (2022 data), https://www.aamc.org/news/women-are-changing-face-medicine-america. Women in residency, 50.2%: ACGME, Data Resource Book, Academic Year 2024-2025, Table C.21, https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf. Corrected 2026-08-13; this page carried ~40% of residents, ten points low. Table C.21 has no behavioral neurology row, since the fellowship is UCNS-certified rather than ACGME-accredited, so the subspecialty figure stays genuinely unpublished. Fill, DO and IMG shares: NRMP, Results and Data: 2026 Main Residency Match, May 2026, Table 2, https://www.nrmp.org/wp-content/uploads/2026/05/Main_Match_Results_and_Data-2026.pdf — neurology offered 1,003 positions and filled 999 of them (99.6%), and those 999 went to 583 US MD seniors, 4 MD graduates, 181 US DO seniors, 7 DO graduates, 49 US IMGs, and 175 non-US IMGs. Both shares are percentages of positions filled: 188 DO is 18.8% and 224 IMG is 22.4%. NRMP's Table 8B reports a different denominator, US DO seniors as a share of positions offered, which gives 18.0%. Corrected 2026-08-17: the body and dashboard had carried ~16.5% DO and ~29% IMG while this footnote already gave the Table 2 figures, so the page disagreed with its own source. The IMG claim was the larger error, nearly seven points high, and the sentence calling neurology's IMG share among the highest of any specialty went with it: internal medicine, pathology, and family medicine all run higher. Swept 2026-08-17: the figures were verified against Table 2 and stand; all eleven profiles in the neurology family now state this pair on this denominator. Corrected 2026-08-17: the framing was rewritten to match the figures. Five sentences here had called neurology "among the more open specialties in medicine," "among the more DO-accessible specialties" and "among the more DO- and IMG-accessible in medicine," and one closed on "the odds are on your side." The all-PGY-1 baselines from the same totals row are 21.5% DO and 25.2% IMG of 38,354 filled positions, which puts neurology just under the ordinary rate on both axes, so each of those sentences now gives the share beside its baseline and leaves the conclusion to the reader. The equivalent sentences on the other ten profiles in the family were changed the same way. What survives is the claim about the UCNS fellowship, which is non-ACGME, undersubscribed, and open on its own evidence. Movement-disorders fellowship fill, ~25% of positions unfilled: see the movement disorders profile on this site; the underlying publisher is NRMP, Results and Data: Specialties Matching Service 2026 Appointment Year, February 2026, Table 1A, https://www.nrmp.org/wp-content/uploads/2026/02/SMS_Results_and_Data_Report2026.pdf. ⟳ ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶
Neurology access and wait times. Neurology, published January 8, 2025 — two years of Medicare claims covering 163,313 beneficiaries referred to neurologists, 84,975 referring physicians and 10,250 neurologists; average wait 34 days, 18% waiting longer than 90 days; average patient age 74; condition-specific waits longer for multiple sclerosis (+29 days over a 30-day back-pain baseline), epilepsy (+10), and Parkinson's disease (+9); no significant variation by regional neurologist supply. American Academy of Neurology press release, "What Is the Average Wait Time to See a Neurologist?" https://www.aan.com/PressRoom/home/PressRelease/5224 ⟳ ↩ ↩² ↩³
Compensation. American Academy of Neurology, Neurology Compensation and Productivity Executive Summary 2025 — ninth annual survey, 4,352 respondents (3,457 neurologists, 815 APPs, 53 administrators) reporting 2024 data, collected February 25 to May 5, 2025 from 13,863 invited AAN members. Neurologist median annual compensation by subspecialty: vascular neurology & stroke $315,913 (n=312), general neurology $309,882 (n=474), epilepsy $282,386 (n=362), child neurology $256,082 (n=300). By practice setting: hospital-based group $362,500 (n=278), multispecialty group $350,000 (n=105), neurology group $315,489 (n=259), solo practice $300,000 (n=31), academic medical center–based group $277,288 (n=2,464), government $255,000 (n=35). Neurologist median wRVUs: academic 2,969, hospital-based 4,863, multispecialty 5,600, neurology group 5,469. The full dashboard covers up to 22 subspecialties and costs $500 for AAN members who did not participate and $2,000 for nonmembers; behavioral neurology is not broken out in the free executive summary. https://www.aan.com/siteassets/home-page/tools-and-resources/practicing-neurologist--administrators/benchmarking-data/neurology-compensation--productivity/25-ncp-executive-summary.pdf . The two national comparisons added 2026-08-13, because the AAN's medians read low against everything else a reader will find: Medscape Physician Compensation Report 2026 (2025 earnings) puts neurology at $341,000 — the primary report is paywalled and returns HTTP 402 — and Doximity's 2025 Physician Compensation Report (2024 earnings, ~37,000 US physicians) puts it at $360,519, openable directly at https://www.doximity.com/reports/physician-compensation-report/2025. Both national surveys publish means across a mixed employment base; the AAN publishes medians from a member panel weighted heavily toward academic practice. Do not average them. ⟳ ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹

Researched with AI assistance and reviewed by hand. How this site is made